A few human studies have provided a promising link of differential gene expression in hyperlipidemia with inflammation and CAD, although there are no current drug therapies targeting these genes such as pro-platelet basic protein (PPBP) and α-defensin (DEFA1/DEFA3) [95]. This evidence concerns the gene PPBP and hyperlipidemia.